Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Samuel

Showing results (431-440 of 451) with videos related to

Pageof 46
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2017
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT studySébastien Dharancy, Audrey Coilly, Claire Fougerou-Leurent, et al.
Journal of Hepatology|June 6, 2016
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT studyAudrey Coilly, Claire Fougerou-Leurent, Victor de Ledinghen, et al.
Journal of Hepatology|April 11, 2019
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the differenceLina Mouna, Emilie Rossignol, Mariagrazia Tateo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 24, 2023
Long-term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 yearsYasmina Chouik, Olivier Chazouillères, Claire Francoz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 12, 2026
Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort StudyFlorian Veyre, Claire Francoz, Domitille Erard, et al.
Journal of Hepatology|September 14, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patientsStanislas Pol, Marc Bourliere, Sandy Lucier, et al.
Journal of Hepatology|January 27, 2021
Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA scoreEleonora De Martin, Audrey Coilly, Olivier Chazouillères, et al.
The American Journal of Gastroenterology|July 30, 2025
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 PatientsFlorian Veyre, Eleonora De Martin, Domitille Erard, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 19, 2018
Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 PatientsOlivier Sérée, Mario Altieri, Elodie Guillaume, et al.
BMC Infectious Diseases|January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosisGeorges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.
Pageof 46

Showing results (431-440 of 451) with videos related to

Sort By:
Pageof 46
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2017
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT studySébastien Dharancy, Audrey Coilly, Claire Fougerou-Leurent, et al.
Journal of Hepatology|June 6, 2016
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT studyAudrey Coilly, Claire Fougerou-Leurent, Victor de Ledinghen, et al.
Journal of Hepatology|April 11, 2019
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the differenceLina Mouna, Emilie Rossignol, Mariagrazia Tateo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 24, 2023
Long-term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 yearsYasmina Chouik, Olivier Chazouillères, Claire Francoz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 12, 2026
Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort StudyFlorian Veyre, Claire Francoz, Domitille Erard, et al.
Journal of Hepatology|September 14, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patientsStanislas Pol, Marc Bourliere, Sandy Lucier, et al.
Journal of Hepatology|January 27, 2021
Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA scoreEleonora De Martin, Audrey Coilly, Olivier Chazouillères, et al.
The American Journal of Gastroenterology|July 30, 2025
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 PatientsFlorian Veyre, Eleonora De Martin, Domitille Erard, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 19, 2018
Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 PatientsOlivier Sérée, Mario Altieri, Elodie Guillaume, et al.
BMC Infectious Diseases|January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosisGeorges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.
Pageof 46